ESSA Pharma Statistics

Total Valuation

ESSA Pharma has a market cap or net worth of $85.13 million. The enterprise value is -$24.93 million.

Market Cap	85.13M
Enterprise Value	-24.93M

Important Dates

The next confirmed earnings date is Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ESSA Pharma has 44.34 million shares outstanding. The number of shares has increased by 0.40% in one year.

Current Share Class	44.34M
Shares Outstanding	44.34M
Shares Change (YoY)	+0.40%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.22%
Owned by Institutions (%)	34.56%
Float	23.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.75
P/TBV Ratio	0.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 69.07

Current Ratio	69.07
Quick Ratio	68.84
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -21.25% and return on invested capital (ROIC) is -15.57%.

Return on Equity (ROE)	-21.25%
Return on Assets (ROA)	-15.25%
Return on Invested Capital (ROIC)	-15.57%
Return on Capital Employed (ROCE)	-27.23%
Revenue Per Employee	n/a
Profits Per Employee	-$721,863
Employee Count	35
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.52% in the last 52 weeks. The beta is 1.56, so ESSA Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	-57.52%
50-Day Moving Average	1.79
200-Day Moving Average	1.83
Relative Strength Index (RSI)	69.31
Average Volume (20 Days)	387,194

Short Selling Information

Short Interest	770,433
Short Previous Month	685,653
Short % of Shares Out	2.23%
Short % of Float	n/a
Short Ratio (days to cover)	1.82

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.66M
Pretax Income	-27.67M
Net Income	-25.27M
EBITDA	n/a
EBIT	-29.66M
Earnings Per Share (EPS)	-$0.57

Full Income Statement

Balance Sheet

The company has $109.62 million in cash and n/a in debt, giving a net cash position of $109.62 million or $2.47 per share.

Cash & Cash Equivalents	109.62M
Total Debt	n/a
Net Cash	109.62M
Net Cash Per Share	$2.47
Equity (Book Value)	108.90M
Book Value Per Share	2.45
Working Capital	108.90M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-20.88M
Capital Expenditures	n/a
Free Cash Flow	-20.88M
FCF Per Share	-$0.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ESSA Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.40%
Shareholder Yield	-0.40%
Earnings Yield	-29.83%
FCF Yield	-24.66%

Analyst Forecast

The average price target for ESSA Pharma is $2.00, which is 4.17% higher than the current price. The consensus rating is "Hold".

Price Target	$2.00
Price Target Difference	4.17%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 25, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date	Apr 25, 2018
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2